Editorial Board — Medscape Gastroenterology

Board Members

  • Paul Martin, MD
    • University of Miami School of Medicine and Hospital
      Miami, Florida
  • Valerio Nobili, MD
    • Bambino Gesù Children's Hospital
      Rome, Italy
  • Nancy S. Reau, MD
    • Department of Internal Medicine
      Rush University
      Rush University Medical Center
      Chicago, Illinois
  • Douglas K. Rex, MD
    • Indiana University
      Indiana University Hospital
      Indianapolis, Indiana
 

Board Member Details

Geoffrey Braden, MD
Geoffrey Braden, MD

Associate Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania; Senior Attending Physician, Intermountain Healthcare, Logan Regional Health, Logan, Utah

Geoffrey L. Braden, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Janssen Biotech; AbbVie Hepatology; AbbVie Immunology
Serve(d) as a speaker or a member of a speakers bureau for: Janssen Biotech; AbbVie Hepatology; AbbVie Immunology
Receive(d) income in an amount equal to or greater than $250 from: Janssen Biotech; AbbVie Hepatology; AbbVie Immunology

Stephen Hanauer, MD
Stephen Hanauer, MD

Professor of Medicine, Medical Director, Digestive Health Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Stephen B. Hanauer, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: AbbVie; Actavis Group; Allergan, Inc.; Amgen, Inc.; Arena Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Celgene; Celltrion; Ferring Pharmaceuticals; Genentech; GlaxoSmithKline; Hospira, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Eli Lilly and Company; Merck & Co; Nestle; Novartis Pharmaceuticals Corporation; Pfizer, Inc.; Prometheus Laboratories Inc.; Receptos; Salix Pharmaceuticals, Inc.; Samsung Bioepis; sanofi-aventis; Seres Health; Shire; Takeda Pharmaceuticals North America, Inc.; TiGenix; UCB Pharma, Inc.; VHsquared
Serve(d) as a speaker or member of a speakers bureau for: AbbVie; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc

Institution received research grant from: AbbVie; Allergan, Inc; Amgen Inc; Celgene; Genentech; GlaxoSmithKline; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Eli Lilly and Company; Novartis Pharmaceuticals Corporation; Pfizer, Inc.; Prometheus Laboratories Inc.; Receptos; sanofi-aventis; Takeda Pharmaceuticals North America, Inc.; UCB Pharma, Inc.

Serve(d) on Data Safety and Monitoring Board for: Bristol-Myers Squibb Company

David A. Johnson, MD
David A. Johnson, MD

Professor of Medicine, Chief of Gastroenterology, Eastern Virginia Medical School, Norfolk, Virginia

David A. Johnson, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Pfizer Inc.; CRH Medical; ARIES; ACG Research Institute; WebMD
Received income in an amount equal to or greater than $250 from: Pfizer Inc.; CRH Medical; ARIES; WebMD

Philip O. Katz, MD
Philip O. Katz, MD

Professor of Medicine; Director, Motility Laboratory, Weill Cornell Medicine, New York, New York

Philip Katz, MD, has disclosed no relevant financial relationships.

Brian E. Lacy, MD, PhD
Brian E. Lacy, MD, PhD

Senior Associate Consultant, Mayo Clinic, Jacksonville, Florida

Brian E. Lacy, MD, PhD, has disclosed the following relevant financial relationships:
Serve(d) on the Board of Trustees for: American College of Gastroenterology
Serve(d) on once-yearly Scientific Advisory Board for: Salix Pharmaceuticals, Inc.; Ironwood Pharmaceuticals, Inc.

Paul Martin, MD
Paul Martin, MD

Professor of Medicine, Department of Medicine, University of Miami School of Medicine; Chief, Division of Gastroenterology and Hepatology, University of Miami Hospital and Clinics, Miami, Florida

Paul Martin, MD, has disclosed the following relevant financial relationships:
Receive(d) research grant from: AbbVie; Gilead; Genfit
Receive(d) income in an amount equal to or greater than $250 from: AbbVie; Merck

Valerio Nobili, MD
Valerio Nobili, MD

Associate Professor of Pediatrics, University of Rome La Sapienza; Director, Hepatology, Gastroenterology, and Nutrition, Bambino Gesù Children’s Hospital, Rome, Italy

Valerio Nobili, MD, has disclosed no relevant financial relationships.

Nancy S. Reau, MD
Nancy S. Reau, MD

Professor, Department of Internal Medicine, Rush University; Section Chief, Hepatology; Associate Director of Organ Transplant, Rush University Medical Center, Chicago, Illinois

Nancy Reau, MD, has disclosed the following financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: AbbVie Inc.; Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Merck & Co., Inc.; Intercept Pharmaceuticals, Inc.
Received income in an amount equal to or greater than $250 from: American Board of Internal Medicine

Douglas K. Rex, MD
Douglas Rex, MD

Douglas K. Rex, MD, Distinguished Professor of Medicine, Indiana University; Director of Endoscopy, Indiana University Hospital, Indianapolis, Indiana

Douglas K. Rex, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant for: Aries Pharmaceutical; Boston Scientific; Olympus
Received research support from: Boston Scientific; Colonary Solutions; Covidien/Medtronic; EndoAid Ltd; Olympus; Paion; Braintree; Sebela